Legal & General Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.91M | Sell |
|
|||||
|
2025
Q2 | $2.81M | Buy |
|
|||||
|
2025
Q1 | $2.97M | Sell |
|
|||||
|
2024
Q4 | $4.55M | Buy |
|
|||||
|
2024
Q3 | $3.6M | Buy |
|
|||||
|
2024
Q2 | $3.08M | Buy |
|
|||||
|
2024
Q1 | $2.99M | Buy |
|
|||||
|
2023
Q4 | $1.93M | Buy |
|
|||||
|
2023
Q3 | $1.59M | Buy |
|
|||||
|
2023
Q2 | $682K | Buy |
|
|||||
|
2023
Q1 | $362K | Buy |
|
|||||
|
2022
Q4 | $292K | Buy |
|
|||||
|
2022
Q3 | $300K | Buy |
|
|||||
|
2022
Q2 | $269K | Buy |
|
|||||
|
2022
Q1 | $313K | Buy |
|
|||||
|
2021
Q4 | $393K | Buy |
|
|||||
|
2021
Q3 | $202K | Buy |
|
|||||
|
2021
Q2 | $96K | Buy |
|
|||||
|
2021
Q1 | $64K | Buy |
|
|||||
|
2020
Q4 | $57K | Hold |
|
|||||
|
2020
Q3 | $63K | Sell |
|
|||||
|
2020
Q2 | $90K | Buy |
|
|||||
|
2020
Q1 | $28K | Sell |
|
|||||
|
2019
Q4 | $54K | Buy |
|
|||||
|
2019
Q3 | $28K | Hold |
|
|||||
|
2019
Q2 | $46K | Buy |
|
|||||
|
2019
Q1 | $33K | Buy |
|
|||||
|
2018
Q4 | $31K | Hold |
|
|||||
|
2018
Q3 | $30K | Buy |
|